Our results suggested that the proportion of CD4+ and CD8+ T lymphocytes and CD4+:CD8+ T ratio has shown slight changes in both lymph nodes and peripheral blood between the treatment groups and the T2DM group. This evidence concerns the gene CD4 and type 2 diabetes mellitus.